Cargando…
Ensuring continued progress for development of COVID-19 therapeutics in children
Autores principales: | Noel, Gary J., DeBiasi, Roberta L., Crandall, Wallace, Connor, Edward M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891471/ https://www.ncbi.nlm.nih.gov/pubmed/33603214 http://dx.doi.org/10.1038/s41390-021-01384-y |
Ejemplares similares
-
Ensuring continuity of care for children with inherited metabolic diseases at the time of COVID-19: the experience of a metabolic unit in Italy
por: Brunetti-Pierri, Nicola, et al.
Publicado: (2020) -
Ensuring global access to COVID-19 vaccines
por: Yamey, Gavin, et al.
Publicado: (2020) -
Key clinical research priorities for the pediatric community during the COVID-19 pandemic
por: Noel, Gary J., et al.
Publicado: (2020) -
A Just Digital framework to ensure equitable achievement of the Sustainable Development Goals
por: O’Sullivan, Katriona, et al.
Publicado: (2021) -
Ensuring the right to health along the life course
por: Nabyonga-Orem, Juliet, et al.
Publicado: (2022)